IP Library › Granted Patent US 8,569,365
Granted Patent B2
US 8,569,365 · App. 11/195,239 · Granted Oct 29, 2013

Compositions and methods for controlling infections

Inventors: Patrick M. Schlievert (Edina, MN); Marnie L. Peterson (Golden Valley, MN)
Assignee: Regents of the University of Minnesota
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,569,365
App. No.
11/195,239
Granted
Oct 29, 2013
Kind
B2
Abstract

The invention features methods of inhibiting the growth of, or killing, fungal and certain bacterial microorganisms with one or more of a family of glycerol-based compounds.

Claims (13)

1. A method of treatment or prophylaxis of a bacterial vaginosis infection in a subject in need thereof, wherein the bacterial vaginosis infection is caused by a bacterial microorganism of the genus Gardnerella , the method comprising:

administering to the subject an effective amount of glycerol monolaurate (GML),

wherein the subject has been exposed to a bacterial microorganism of the genus Gardnerella.

2. The method of claim 1 , wherein the subject is a vertebrate.

3. The method of claim 2 , wherein the vertebrate is a mammal.

4. The method of claim 3 , wherein the mammal is a human.

5. The method of claim 1 , further comprising: before, simultaneous with, or after the administration of the glycerol monolaurate (GML), administering one or more supplementary agents.

6. The method of claim 5 , wherein the one or more supplementary agents are antibiotics.

7. The method of claim 1 , where Gardnerella bacterial microorganism is a Gardnerella vaginalis bacterial microorganism.

8. The method of claim 1 , wherein the glycerol monolaurate (GML) is present in a composition comprising one or more pharmaceutical excipients.

9. The method of claim 7 , wherein the glycerol monolaurate (GML) is present in a composition comprising one or more pharmaceutical excipients.

10. The method of claim 8 , wherein the glycerol monolaurate (GML) is administered to the subject at a dosage of 0.0001-100 mg/kg.

11. The method of claim 9 , wherein the glycerol monolaurate (GML) is administered to the subject at a dosage of 0.0001-100 mg/kg.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2005
From: SCHLIEVERT, PATRICK M.; PETERSON, MARNIE L.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 017107/0997 →
Continuity (2)
Provisional Application 60598240 · Aug 3, 2004
Related Publication 20060029558A1 · Feb 9, 2006